Literature DB >> 30423177

Habitual light exposure relative to circadian timing in delayed sleep-wake phase disorder.

John Wilson1,2, Kathryn J Reid1,2, Rosemary I Braun3,4, Sabra M Abbott1,2, Phyllis C Zee1,2.   

Abstract

Study
Objectives: To compare melatonin timing, a well-validated marker for endogenous circadian phase, and habitual light-exposure patterns in adults with delayed sleep-wake phase disorder (DSWPD) and intermediate chronotype controls.
Methods: Twelve individuals with DSWPD (five females, mean age: 31.1) and 12 age-matched controls (six females, mean age: 33.6) underwent a minimum of 7 days of light and activity monitoring followed by an inpatient hospital stay, where blood was taken to assess melatonin timing (calculated as dim light melatonin onset-DLMO). Habitual light-exposure patterns were then compared with a human phase-response curve (PRC) to light.
Results: Relative to clock time, individuals with DSWPD had a later light-exposure pattern compared with controls, but their light-exposure pattern was earlier relative to DLMO. According to the human PRC to light, individuals with DSWPD had less daily advancing light exposure compared with controls. The primary difference was seen in the late portion of the advancing window, in which individuals with DSWPD were exposed to fewer pulses of light of equivalent duration and intensity compared with controls. Conclusions: Diminished advancing light exposure may play a role in the development and perpetuation of delayed sleep-wake timing in individuals with DSWPD. Enhancing light exposure during the later portion of the advancing window represents an innovative and complementary strategy that has the potential to improve the effectiveness of bright light therapy in DSWPD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30423177      PMCID: PMC6231529          DOI: 10.1093/sleep/zsy166

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  33 in total

1.  Daily light exposure in morning-type and evening-type individuals.

Authors:  Geneviève Goulet; Valérie Mongrain; Catherine Desrosiers; Jean Paquet; Marie Dumont
Journal:  J Biol Rhythms       Date:  2007-04       Impact factor: 3.182

Review 2.  The etiology of delayed sleep phase disorder.

Authors:  Gorica Micic; Nicole Lovato; Michael Gradisar; Sally A Ferguson; Helen J Burgess; Leon C Lack
Journal:  Sleep Med Rev       Date:  2015-07-03       Impact factor: 11.609

3.  Altered phase relation between sleep timing and core body temperature rhythm in delayed sleep phase syndrome and non-24-hour sleep-wake syndrome in humans.

Authors:  M Uchiyama; M Okawa; K Shibui; K Kim; H Tagaya; Y Kudo; Y Kamei; T Hayakawa; J Urata; K Takahashi
Journal:  Neurosci Lett       Date:  2000-11-17       Impact factor: 3.046

4.  Timing of light exposure and activity in adults with delayed sleep-wake phase disorder.

Authors:  Eun Yeon Joo; Sabra M Abbott; Kathryn J Reid; Donghong Wu; Joseph Kang; John Wilson; Phyllis C Zee
Journal:  Sleep Med       Date:  2016-11-09       Impact factor: 3.492

5.  Entrainment of the human circadian clock to the natural light-dark cycle.

Authors:  Kenneth P Wright; Andrew W McHill; Brian R Birks; Brandon R Griffin; Thomas Rusterholz; Evan D Chinoy
Journal:  Curr Biol       Date:  2013-08-01       Impact factor: 10.834

6.  Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder.

Authors:  Roneil G Malkani; Sabra M Abbott; Kathryn J Reid; Phyllis C Zee
Journal:  J Clin Sleep Med       Date:  2018-04-15       Impact factor: 4.062

Review 7.  Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. An American Academy of Sleep Medicine review.

Authors:  Robert L Sack; Dennis Auckley; R Robert Auger; Mary A Carskadon; Kenneth P Wright; Michael V Vitiello; Irina V Zhdanova
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

8.  Circadian Melatonin and Temperature Taus in Delayed Sleep-wake Phase Disorder and Non-24-hour Sleep-wake Rhythm Disorder Patients: An Ultradian Constant Routine Study.

Authors:  Gorica Micic; Nicole Lovato; Michael Gradisar; Helen J Burgess; Sally A Ferguson; Leon Lack
Journal:  J Biol Rhythms       Date:  2016-06-16       Impact factor: 3.182

Review 9.  Effects of blue light on the circadian system and eye physiology.

Authors:  Gianluca Tosini; Ian Ferguson; Kazuo Tsubota
Journal:  Mol Vis       Date:  2016-01-24       Impact factor: 2.367

Review 10.  Mammalian circadian biology: elucidating genome-wide levels of temporal organization.

Authors:  Phillip L Lowrey; Joseph S Takahashi
Journal:  Annu Rev Genomics Hum Genet       Date:  2004       Impact factor: 8.929

View more
  5 in total

Review 1.  Assessment of Circadian Rhythms.

Authors:  Kathryn J Reid
Journal:  Neurol Clin       Date:  2019-08       Impact factor: 3.806

2.  A Mixed Method Examination of Sleep Patterns and Barriers to Sleep in Hispanic Women.

Authors:  Julia Roncoroni; Rocio I Pereira; Margaret Schultz Patel; Patricia García
Journal:  J Immigr Minor Health       Date:  2021-09-16

3.  Workshop report. Circadian rhythm sleep-wake disorders: gaps and opportunities.

Authors:  Jeanne F Duffy; Sabra M Abbott; Helen J Burgess; Stephanie J Crowley; Jonathan S Emens; Lawrence J Epstein; Karen L Gamble; Brant P Hasler; David A Kristo; Roneil G Malkani; Shadab A Rahman; S Justin Thomas; James K Wyatt; Phyllis C Zee; Elizabeth B Klerman
Journal:  Sleep       Date:  2021-05-14       Impact factor: 5.849

4.  The Clinical Effect of Blue Light Therapy on Patients with Delayed Sleep-Wake Phase Disorder.

Authors:  Dong Li; Penghong Fang; Huimiao Liu; Lili Chen; Ying Fu; Junqian Liu; Bingchuan Xie; Yihan Liu; Hongyuan Ye; Ping Gu
Journal:  Nat Sci Sleep       Date:  2022-01-18

5.  Optimized office lighting advances melatonin phase and peripheral heat loss prior bedtime.

Authors:  Marta Benedetti; Lenka Maierová; Christian Cajochen; Jean-Louis Scartezzini; Mirjam Münch
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.